| |
| |
|
| Insider
Information: |
Opaleye Management Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
11,357,063 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$69,327,006 |
|
|
| Total
Shares |
11,357,063 |
|
|
| Total
Value |
$69,327,006 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
123
|
8
|
|
Stock
price went up :
|
64
|
1
|
| Stock
price went down : |
59
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
1.1
|
1.1
|
| Percentage
Gain/Loss : |
 15.1%
|
 -143.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harrow Health Inc |
HROW |
10% Owner |
2015-05-19 |
0 |
2024-04-25 |
3,815,000 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
|
0 |
2020-01-02 |
4,918,500 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
10% Owner |
|
0 |
2021-11-17 |
2,375,000 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2020-08-27 |
0 |
2023-11-10 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2020-09-24 |
0 |
2024-05-22 |
123,750 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2022-06-10 |
0 |
2022-11-03 |
124,813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
160 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-07-09 |
4 |
B |
$4.82 |
$145,079 |
I/I |
30,000 |
130,000 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-09 |
4 |
S |
$3.09 |
$94,526 |
I/I |
(30,600) |
2,531,994 |
0 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-21 |
4 |
S |
$3.06 |
$100,838 |
I/I |
(33,000) |
124,250 |
0 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-10-11 |
4 |
S |
$5.01 |
$170,716 |
I/I |
(34,101) |
112,807 |
0 |
- |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2015-06-30 |
4 |
B |
$7.90 |
$276,500 |
I/I |
35,000 |
1,205,000 |
1.5 |
- |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-06-19 |
4 |
B |
$5.58 |
$195,402 |
I/I |
35,000 |
2,585,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-01-21 |
4 |
B |
$2.19 |
$76,811 |
I/I |
35,000 |
315,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-12-18 |
4 |
B |
$5.31 |
$193,379 |
I/I |
36,400 |
133,300 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-27 |
4 |
B |
$6.53 |
$239,713 |
I/I |
36,700 |
110,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-09-01 |
4 |
B |
$2.04 |
$81,768 |
I/I |
40,000 |
1,540,946 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-07-07 |
4 |
B |
$5.18 |
$213,996 |
I/I |
41,300 |
2,626,300 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2021-12-14 |
4 |
B |
$2.53 |
$106,344 |
I/I |
42,000 |
250,711 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-04-22 |
4 |
B |
$2.24 |
$93,941 |
I/I |
42,000 |
334,337 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-10-08 |
4 |
S |
$5.00 |
$218,469 |
I/I |
(43,692) |
114,408 |
0 |
- |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2016-03-11 |
4 |
B |
$3.65 |
$164,250 |
I/I |
45,000 |
1,250,000 |
1.5 |
- |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-07-10 |
4 |
B |
$4.98 |
$223,965 |
I/I |
45,000 |
2,761,300 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-08-18 |
4 |
B |
$8.64 |
$401,979 |
I/I |
46,500 |
147,500 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-07-11 |
4 |
B |
$4.96 |
$231,922 |
I/I |
46,800 |
2,808,100 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-09-09 |
4 |
B |
$3.47 |
$164,773 |
I/I |
47,500 |
1,709,438 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-05-25 |
4 |
S |
$8.53 |
$409,440 |
I/I |
(48,000) |
153,000 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2020-09-30 |
4 |
B |
$16.00 |
$800,000 |
I/I |
50,000 |
2,458,472 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2021-12-01 |
4 |
B |
$2.40 |
$120,160 |
I/I |
50,000 |
230,000 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-06-22 |
4 |
B |
$6.50 |
$324,975 |
I/I |
50,000 |
1,540,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-03-28 |
4 |
B |
$12.82 |
$641,000 |
I/I |
50,000 |
3,745,600 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-03-20 |
4 |
B |
$9.65 |
$488,290 |
I/I |
50,600 |
3,695,600 |
1.5 |
% |
|
160 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
